Equitec Specialists’s MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share MPLN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-164,756
Closed -$159K 123
2021
Q1
$159K Sell
164,756
-251,567
-60% -$333K 0.03% 132
2020
Q4
$624K Buy
+416,323
New +$630K 0.04% 79

Other funds holding MPLN.WS

Equitec Specialists's MPLN.WS Position: Q2 2021 in Review

Equitec Specialists sold out of MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share (MPLN.WS) in Q2 2021, closing a stake of 164,756 shares — an estimated $159K sold.

Equitec Specialists first reported a position in MPLN.WS in Q4 2020 and held it in 2 quarters. The position peaked at $624K in Q4 2020. 28 funds tracked by Wall St. Rank hold MPLN.WS as of Q2 2021.

  • Equitec Specialists reported no remaining MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q2 2021 after selling out during the quarter.
  • Equitec Specialists sold 164,756 MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q2 2021, an estimated $159K.
  • Equitec Specialists first reported a position in MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q4 2020 and held it in 2 quarters.
  • Equitec Specialists's MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $624K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q2 2021.

Based on Equitec Specialists's 13F filing for Q2 2021, filed 20 Jul 2021.